| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/17/2001 | WO2001034624A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
| 05/17/2001 | WO2001034623A1 29 human secreted proteins |
| 05/17/2001 | WO2001034621A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | WO2001028353A8 Protein hydrolysates produced with the use of marine proteases |
| 05/17/2001 | WO2001020016A3 Method for increasing the yield of recombinant proteins in microbial fermentation processes |
| 05/17/2001 | WO2001019861A3 Apo-2 receptor antibodies |
| 05/17/2001 | WO2001007607A3 FULL LENGTH cDNA CLONES AND PROTEINS ENCODED THEREBY |
| 05/17/2001 | WO2001007471A9 Cell cycle and proliferation proteins |
| 05/17/2001 | WO2001004157A3 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 05/17/2001 | WO2000077166A3 Gene expression modulated in gastrointestinal inflammation |
| 05/17/2001 | WO2000049038A9 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 05/17/2001 | WO2000033077A9 Cell matrix plaques of initial bone formation |
| 05/17/2001 | WO1999044620A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 05/17/2001 | WO1995002040A3 New stromal cell lines from human bone marrow and their use |
| 05/17/2001 | US20010001310 Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes |
| 05/17/2001 | US20010001290 Methods for enhancing the production of viral vaccines in cell culture |
| 05/17/2001 | DE10019473A1 Polypeptid-Tag's für den Nachweis und die Aufreinigung von Polypeptiden Polypeptide tag's for the detection and purification of polypeptides |
| 05/17/2001 | CA2428827A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2391369A1 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 05/17/2001 | CA2390995A1 Recombinant gelatin in vaccines |
| 05/17/2001 | CA2390646A1 Compositions and methods for regulating endogenous inhibitor of atp synthase, including treatment for diabetes |
| 05/17/2001 | CA2390438A1 19 human secreted proteins |
| 05/17/2001 | CA2390421A1 24 human secreted proteins |
| 05/17/2001 | CA2390374A1 Diagnosis and treatment of malignant neoplasms |
| 05/17/2001 | CA2389841A1 Novel nucleic acid molecules encoding cyclised amino acid sequences |
| 05/17/2001 | CA2389724A1 28 human secreted proteins |
| 05/17/2001 | CA2389330A1 Kringle domain-containing polynucleotides, polypeptides, and antibodies |
| 05/17/2001 | CA2389326A1 35 human secreted proteins |
| 05/17/2001 | CA2389305A1 28 human secreted proteins |
| 05/17/2001 | CA2389204A1 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 05/17/2001 | CA2388914A1 15 human secreted proteins |
| 05/17/2001 | CA2388912A1 6 human secreted proteins |
| 05/17/2001 | CA2388477A1 Recombinant gelatins with uniform molecular weight |
| 05/17/2001 | CA2388008A1 29 human secreted proteins |
| 05/17/2001 | CA2387964A1 22 human secreted proteins |
| 05/17/2001 | CA2387959A1 21 human secreted proteins |
| 05/17/2001 | CA2382348A1 Methods for identifying compounds that affect rna/rna binding protein interactions |
| 05/17/2001 | CA2359955A1 Human vanilloid receptor gene |
| 05/17/2001 | CA2325226A1 Use of polypeptides or nucleic acids encoding these for the diagnosis or treatment of skin disorders, and their use for the identification of pharmacologically active substances |
| 05/16/2001 | EP1099758A2 Method and host cells for producing two-chain relaxin polypeptide |
| 05/16/2001 | EP1098981A1 A mutant human hepatitis b viral strain and uses thereof |
| 05/16/2001 | EP1098979A2 Fap alpha-specific antibody with improved producibility |
| 05/16/2001 | EP1098978A1 Gbs toxin receptor |
| 05/16/2001 | EP1098975A1 Orphan cytokine receptor |
| 05/16/2001 | EP1098974A2 Nucleotide sequences and amino acid sequences of secreted proteins involved in angiogenesis |
| 05/16/2001 | EP1098973A1 Human lcb kinase 1 |
| 05/16/2001 | EP1098972A1 Protein similar to neuroendocrine-specific protein, and encoding cdna |
| 05/16/2001 | EP1098970A1 Human sbpsapl gene with homology to the prosaposin family of neurotrophic factors |
| 05/16/2001 | EP1098909A1 Hybrid human/rodent igg antibody to cd3, and methods of its construction |
| 05/16/2001 | EP1098908A2 Anti-ccr2 antibodies and methods of use therefor |
| 05/16/2001 | EP1098904A1 Axor10, a g-protein coupled receptor |
| 05/16/2001 | EP1098665A1 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
| 05/16/2001 | EP0810870B1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/16/2001 | CN1295620A Protein expression in baculovirus vector expression system |
| 05/16/2001 | CN1295617A Variants of angiogenic factor vascular endothelial cell growth factor: VEGF |
| 05/16/2001 | CN1295614A Modulator for function of receptor of TNF/NGF receptor family and other protein |
| 05/16/2001 | CN1295580A Method for producing mouse and haman endogenous vascular formation inhibition factor |
| 05/16/2001 | CN1295484A Formulations for protection of PEG-interferon alpha conjugates |
| 05/16/2001 | CN1065913C Disinfect peptide-X gene structure, prodn tech. and use thereof |
| 05/16/2001 | CN1065875C Fibrillating cell growth factor-2 and analogue and its production method and use |
| 05/16/2001 | CN1065864C Aylucone isoflavone enriched regetable protein whey, whey protein, and process for producing same |
| 05/16/2001 | CN1065768C Methods of treatment of motor neuron cliseases using members of BDNF/NT-3/NGF family of molecule |
| 05/15/2001 | US6232460 Isolated nucleic acid molecule which encodes an SCP-1 mutein |
| 05/15/2001 | US6232459 Synaptojanin isoform |
| 05/15/2001 | US6232458 Proteins used in pharmaceutical human and veterinary applications; adapted to provide enhanced expression |
| 05/15/2001 | US6232452 Autosomal dominant disorder of growths in many tissues and organs identified on chromosome 16 deletion mutations; use in disease diagnosis and screening; the gene may behave as a tumor suppressor |
| 05/15/2001 | US6232449 Persephin and related growth factors |
| 05/15/2001 | US6232448 Immunological materials and methods for detecting dihydropyrimidine dehydrogenase |
| 05/15/2001 | US6232447 Antibody immunoreactive with a human cytokine designated LERK-6 |
| 05/15/2001 | US6232445 Soluble MHC complexes and methods of use thereof |
| 05/15/2001 | US6232443 Useful markers in diagnosing and monitoring cancerous renal cells; detecting cell proliferative disorders |
| 05/15/2001 | US6232441 PIGR-1, a member of immunoglobulin gene superfamily |
| 05/15/2001 | US6232286 Methods of stimulating mitogenesis in glial cells using glial mitogenic factors |
| 05/15/2001 | US6232123 Immunoglobulin for the diagnosis and treatment of tumors, leukemias, lymphomas and autoimmune diseases |
| 05/15/2001 | US6232117 Expression vector wchich codes preferential controlling protein associated with transformation; for use as tool in genetic engineering |
| 05/15/2001 | US6232108 Prenylcysteine carboxyl methyltransferase, DNA encoding same, and a method of screening for inhibitors thereof |
| 05/15/2001 | US6232107 Nucleotide sequence coding green fluorescent protein; for use in diagnosis of microorganism infection |
| 05/15/2001 | US6232094 DNA encoding human κ casein and process for obtaining the protein |
| 05/15/2001 | US6232082 Vaccines |
| 05/15/2001 | US6231861 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
| 05/15/2001 | US6231856 Methods and compositions for treatment of autoimmune diseases |
| 05/15/2001 | US6231855 Side effect reduction |
| 05/15/2001 | CA2183268C Bispecific molecules having clinical utilities |
| 05/15/2001 | CA2083948C Glyphosate tolerant plants |
| 05/15/2001 | CA2078858C Expression of heterologous protein in yeast |
| 05/15/2001 | CA2041638C Recombinant polynucleotide constructs suitable for providing secretion of pai-2 |
| 05/15/2001 | CA1341231C Primary biliary cirrhosis autoantigen |
| 05/15/2001 | CA1341230C Amino acid sequence of l-phenylalanine ammonia-lyase, structural gene thereof, novel dna sequence containing same, novel recombinant dna plasmid containing same transformant formed therewith, and process for the production of l-phenylalanine by using same |
| 05/15/2001 | CA1341229C Procoagulant proteins derived from factor viii: c |
| 05/15/2001 | CA1341228C Expression of protein c |
| 05/15/2001 | CA1341227C Human transforming growth factor alpha |
| 05/10/2001 | WO2001033221A1 Axor35, a g-protein coupled receptor |
| 05/10/2001 | WO2001032927A2 Tissue specific genes of diagnostic import |
| 05/10/2001 | WO2001032910A2 27 human secreted proteins |
| 05/10/2001 | WO2001032908A1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 05/10/2001 | WO2001032906A2 Oligomers and oligomeric segments of alpha-hydroxy carboxylic acids and alpha-amino acids |
| 05/10/2001 | WO2001032905A1 Process for producing a product containing antihypertensive tripeptides |
| 05/10/2001 | WO2001032901A1 Expression vectors, transfection systems, and method of use thereof |
| 05/10/2001 | WO2001032893A1 Recombinant therapeutic fusion proteins |
| 05/10/2001 | WO2001032882A2 Nucleic acids and proteins from group b streptococcus |